Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure

New England Journal of Medicine

Volumn 350, Issue 21, 2004, Pages 2140-2150+2227

  Bristow, Michael R ^a   Saxon, Leslie A ^b   Boehmer, John ^c   Krueger, Steven ^d   Kass, David A ^e   De Marco, Teresa ^f   Carson, Peter ^g   DiCarlo, Lorenzo ^h   DeMets, David ⁱ   White, Bill G ^j   DeVries, Dale W ^k   Feldman, Arthur M ^l  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d Bryan LGH Medical Center   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

^f UCSF Medical Center at Parnassus   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h PFIZER INC   (United States)

ⁱ UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^j Clinical Cardiovascular Research   (United States)

^k BOSTON SCIENTIFIC CORPORATION   (United States)

^l THOMAS JEFFERSON UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOOP DIURETIC AGENT; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DIABETES MELLITUS; FEMALE; HEART ASSIST DEVICE; HEART BUNDLE BRANCH BLOCK; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE; HEART RESYNCHRONIZATION THERAPY; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROPHYLAXIS; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME; CHRONIC DISEASE; CONGESTIVE HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; RISK;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; DIURETICS; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; PACEMAKER, ARTIFICIAL; RISK; SPIRONOLACTONE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 2442479695     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa032423     Document Type: Article

References (21)

1. Trautmann SI, Kloss M, Auricchio A. Cardiac resynchronization therapy. Curr Cardiol Rep 2002;4:371-8.
2. Abraham WT. Cardiac resynchronization therapy for heart failure: biventricular pacing and beyond. Curr Opin Cardiol 2002;17:346-52.
3. Shamim W, Francis DP, Yousufuddin M, et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol 1999;70:171-8.
4. Baldasseroni S, Opasich C, Gorini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian Network on Congestive Heart Failure. Am Heart J 2002;143:398-405.
5. Werling C, Weisse U, Siemon G, et al. Biventricular pacing in patients with ICD: how many patients are possible candidates? Thorac Cardiovasc Surg 2002;50:67-70.
6. Nelson GS, Berger RD, Fetics BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000;102:3053-9. [Erratum, Circulation 2001;103:476.]
7. Nelson GS, Berger RD, Fetics BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000;102:3053-9. [Erratum, Circulation 2001;103:476.]
8. Sogaard P, Kim WY, Jensen HK, et al. Impact of acute biventricular pacing on left ventricular performance and volumes in patients with severe heart failure: a tissue Doppler and three-dimensional echocardiographic study. Cardiology 2001;95:173-82.
9. Kawaguchi M, Murabayashi T, Fetics BJ, et al. Quantitation of basal dyssynchrony and acute resynchronization from left or biventricular pacing by novel echo-contrast variability imaging. J Am Coll Cardiol 2002;39:2052-8.
10. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
11. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart figure: results from the MUltisite STimulation In Cardiomyopathies (MUSTIC) study. J Am Coll Cardiol 2002;40:111-8.
12. Auricchio A, Stellbrink C, Sack S, et al. Long-term effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-33.
13. Higgins SL, Hummel JD, Niazi IA, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrythmias. J Am Coll Cardiol 2003;42:1454-9.
14. Saxon LA, De Marco T, Schafer J, et al. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 2002;105:1304-10.
15. Sogaard P, Egeblad H, Kim WY, et al. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol 2002;40:723-30.
16. St John Sutton MG, Plappert T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985-90.
17. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
18. Bristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for intraventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) Trial. J Card Fail 2000;6:276-85.
19. Auricchio A, Kramer A, Spinelli JC, et al. Can the optimum dosage of resynchronization therapy be derived from the intracardiac electrogram? J Am Coll Cardiol 2002;39: Suppl A:124A. abstract.
20. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-56.
21. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:649-53.